Skip to main navigation Skip to search Skip to main content

Antitumor effect of interleukin-2 (IL-2) mini-pellet plus LAK cells on Meth-A sarcoma in mice

  • Toshiyoshi Fujiwara
  • , Ken ichi Sakagami
  • , Junji Matsuoka
  • , Shigehiro Shiozaki
  • , Susumu Uchida
  • , Takenori Kawamura
  • , Shinji Takasu
  • , Futoshi Morisaki
  • , Shinya Saito
  • , Toshihiko Owa
  • , Minoru Haisa
  • , Masaru Inagaki
  • , Kunzo Orita

Research output: Contribution to journalArticlepeer-review

Abstract

We have evaluated the antitumor effect of IL-2 mini-pellet on the therapy of murine Meth-A sarcoma. After the administration of IL-2 mini-pellet containing 1×106u of IL-2, the serum IL-2 activity was detectable for 72 hours. The s. c. administration of IL-2 mini-pellet and the i. v. injection of LAK cells was effective in inhibiting the tumor growth and could also prolong the survivals. The lytic activites of splenocytes against YAC-1 cells and JTC-11 cells after the administration of IL-2 mini-pellet were augmented. In histological examination on day 7 after the administration of IL-2 mini-pellet, a lot of lymphocytes were invased into tumor tissues. These results suggest that IL-2 mini-pellet can be applied to the adoptive immunotherapy using LAK cells.

Original languageEnglish
Pages (from-to)437-443
Number of pages7
JournalDrug Delivery System
Volume3
Issue number3
DOIs
Publication statusPublished - 1988

Keywords

  • LAK cells
  • Meth-A sarcoma
  • adoptive immunotherapy
  • interleukin-2

ASJC Scopus subject areas

  • Pharmaceutical Science

Fingerprint

Dive into the research topics of 'Antitumor effect of interleukin-2 (IL-2) mini-pellet plus LAK cells on Meth-A sarcoma in mice'. Together they form a unique fingerprint.

Cite this